PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris-BIO), a company dedicated to the supportive care and treatment of cancer patients, today published its consolidated financial results for the fiscal year ending December 31, 2010.
